Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B
Condition:   Chronic Hepatitis b Interventions:   Drug: ABI-H0731;   Drug: Placebo for ABI-H0731;   Drug: Entecavir;   Drug: Tenofovir Disoproxil Fumarate;   Drug: Pegasys Sponsor:   Assembly Biosciences Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2017 Category: Research Source Type: clinical trials

The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC
Condition:   Hepatitis B Interventions:   Drug: Peginterferon Alfa-2A;   Drug: Adefovir, entecavir,tenofovir, either of them Sponsor:   Shanghai Nanhui Nanhua Hospital Active, not recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2017 Category: Research Source Type: clinical trials